Ontology highlight
ABSTRACT: Introduction
Cardiac implantable electronic device (CIED) leads frequently develop echogenic masses. However, the nature of these masses is not well understood. In patients in whom atrial fibrillation (AF) catheter ablation is planned, there is concern that transseptal puncture may result in cerebrovascular embolism of these masses. The optimal therapeutic strategy in this setting remains undefined.Methods
We describe six patients identified over a 6-year period (2008-2014) with device lead-based masses prior to or at the time of AF ablation. We examined the anticoagulation strategy and periprocedural management based on mass identification.Results
In all six patients (age 39-73; four males), the device lead mass was found in the right atrium. The average mass size
SUBMITTER: Lenz CJ
PROVIDER: S-EPMC5077628 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature